Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock on Tuesday when an expert panel overwhelmingly voted to recommend that the Food and Drug Administration ...

After a remarkably sensational regulatory drug review, advisers for the Food and Drug Administration on Tuesday voted overwhelmingly against approving midomafetamine (MDMA, aka ecstasy or molly) as ...

A panel of advisers to the U.S. health regulator on Tuesday voted against a therapy based on the party drug MDMA for patients with post-traumatic stress disorder, in a major setback to the nascent ...

A federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder. The novel treatment has the ...

Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by the Center for Psychedelic Therapy Research shows a Yehuda Lab MDMA-assisted therapy treatment room at the ...

Add Yahoo as a preferred source to see more of our stories on Google. The research that the FDA considered was spearheaded by the Multidisciplinary Association for Psychedelic Studies (MAPS), which ...

The Food and Drug Administration’s (FDA) recent rejection of midomafetamine (MDMA), along with mental health therapy, for the treatment of post-traumatic stress disorder (PTSD) came as no surprise.

Medical research into using the psychedelic MDMA to treat post-traumatic stress disorder is being called into question following allegations that a clinical trial investigating the treatment was ...

Every time Shubhangi publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort ...